RA
INSIDER · LGND · LIGAND PHARMACEUTICALS INC · CLO & SECRETARY
Reardon Andrew
Every open-market transaction filed under this name, Sep 3 to Sep 3.
Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$1.4M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 400 | $288.98 | $116K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 385 | $287.53 | $111K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 2,115 | $286.36 | $606K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 1,800 | $285.17 | $513K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 300 | $283.99 | $85K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.